FDA inspection
Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy: FDA inspection ending Dec 18, 2017
FDA inspection 1035243 · Murrieta, CA
Key facts
| Inspection ID | 1035243 |
|---|---|
| Firm | Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy |
| FEI number | 3013556857 |
| Address | 41538 Eastman Dr Ste A |
| City | Murrieta |
| State | CA |
| ZIP | 92562-8007 |
| Fiscal year | 2018 |
| Inspection end date | Dec 18, 2017 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 555295 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data